Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.100 (11.05%)
At close: Jul 6, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $7.15 million as of July 6, 2026. Its market cap has decreased by -25.47% in one year.
Market Cap
7.15M
Enterprise Value
10.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 7.15M, a decrease of -68.00%. That is a compound annual growth rate of -6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 7.15M | 23.46% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 10.34M |
| Reviva Pharmaceuticals Holdings | 8.65M |
| Synlogic | 8.20M |
| NKGen Biotech | 7.84M |
| TRON Group | 6.44M |
| Mosaic ImmunoEngineering | 4.88M |
| Enzolytics | 4.35M |
| GPL Holdings | 4.20M |